Li Zhilin 4
4 · CHINA PHARMA HOLDINGS, INC. · Filed Oct 19, 2023
Insider Transaction Report
Form 4
Li Zhilin
DirectorCEO & Interim CFO10% Owner
Transactions
- Award
Common Stock
2023-09-29$0.14/sh+13,757,063$1,925,989→ 15,138,063 total
Footnotes (2)
- [F1]On September 29, 2023, the reporting person was granted 13,757,063 shares of Issuer's common stock pursuant to certain loan settlement agreement with the Company to settle a loan in the amount of $1,854,452.10 that the Company owed to the reporting person.
- [F2]After giving effect to the 1-for-10 reverse stock split on March 6, 2023, resulting 13,810,000 shares the reporting person previously owned being 1,381,000 shares.